Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Person › Details

Walter Stockinger (Hadean Ventures (NO))

Stockinger, Walter (Hadean Ventures 201712 Managing Partner)

 

Organisation Organisation Hadean Ventures (NO)
Products Product venture capital
  Product 2 LIFE SCIENCES
     

Hadean Ventures. (12/18/17). "Press Release: Hadean Ventures Launches New Fund to Leverage Untapped Potential of European Life Science Start-ups". Oslo & Stockholm.

Hadean Ventures announced today the closing of Hadean Capital I, a new fund with a target size of €100 million that will invest in life science companies. A particular attention will be given to regions of Europe harbouring world class scientific communities, yet are under-served from a venture capital perspective, especially the Nordic region. The fund is supported by a consortium of blue chip fund investors, including Argentum, Saminvest, Gjensidigestiftelsen, OPF and Varner.

Ingrid Teigland Akay, Managing Partner of Hadean Ventures, says: “Several European countries have built world class scientific communities on the basis of longstanding tradition for scientific excellence and significant investments in research. In addition, the growing ecosystem and surge in entrepreneurship have created a very fertile ground for life science start-ups. In particular, the Nordic region has outstanding scientists, a stable, business friendly environment and a vibrant start-up community, yet very few life science specialist venture funds are on the ground. We see an exceptionally strong deal flow of high potential opportunities here.”

Walter Stockinger, Managing Partner of Hadean Ventures, points out that “the availability of venture capital for life science start-ups has not kept pace with the recent entrepreneurial boom. Other industries have seen several new VC funds emerge, supporting and benefiting from the surge in young and innovative companies, whereas the complexity of the healthcare sector presents a particularly high hurdle. Our team combines the necessary life science know-how with many years of VC experience, which we believe enables us to identify and accelerate high potential life science start-ups and benefit from the particularly fertile environment.”

Joachim Høegh-Krohn, CEO of Argentum, says: “We invest in Hadean Ventures because we believe in the healthcare growth potential and Hadean Ventures' ability to find and further develop companies that solve tomorrow's health challenges”.

“I am delighted that Saminvest invests in the emerging team of Hadean Ventures. We firmly believe that the new fund is well positioned to take advantage of the investment opportunities in the fast growing and innovative life science sector in Scandinavia”, says Peder Hasslev, Chief Executive Officer at Saminvest.

Hadean Ventures has offices in Oslo and Stockholm and collaborates with start-up hubs across the region.

   
Record changed: 2021-06-28

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80


More documents for Walter Stockinger


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top